Mission

The mission of Oxygen Biotherapeutics is to research, develop and market oxygen related topical and intravenous products based on our perfluorocarbon technology.  Our dedicated team is driven by the promise of utilizing perfluorocarbons for saving lives, maintaining health and improving quality of life through improved oxygen delivery to tissues and organs.

 

  • Funds breathe new life into Oxygen Biotherapeutics

By DAVID RANII
Posted on Wednesday, Jan. 25, 2012

After a tumultuous year that featured the dismissal of its CEO, drug-development company Oxygen Biotherapeutics is starting 2012 in its best financial shape in years.
The small, publicly traded Morrisville company turned a financial corner at the end of last year when it sold $7.5 million in preferred stock and warrants to institutional investors. The company received $3.5 million in December, with the second installment expected midyear.

In the past, Oxygen Bio has raised money that would carry it forward for about six months, but this was a richer deal. More...

Quick Links